2022
DOI: 10.1016/j.compbiomed.2022.106084
|View full text |Cite
|
Sign up to set email alerts
|

RCMNet: A deep learning model assists CAR-T therapy for leukemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2
1
1

Relationship

3
7

Authors

Journals

citations
Cited by 21 publications
(10 citation statements)
references
References 27 publications
0
10
0
Order By: Relevance
“…Use of NLP in the field of CAR-T therapy is extremely rare. As of January 2023, we found no references in the Web of Science engine while the Scopus search engine produced one relevant, extremely recent research paper by Zhang et al ( 26 ). We therefore believe that our application of advanced NLP to mine and analyze CAR-T government regulations is the first of its kind in the pharmaceutical industry.…”
Section: Methodsmentioning
confidence: 87%
“…Use of NLP in the field of CAR-T therapy is extremely rare. As of January 2023, we found no references in the Web of Science engine while the Scopus search engine produced one relevant, extremely recent research paper by Zhang et al ( 26 ). We therefore believe that our application of advanced NLP to mine and analyze CAR-T government regulations is the first of its kind in the pharmaceutical industry.…”
Section: Methodsmentioning
confidence: 87%
“…The involvement of AI facilitates the diagnosis of diseases by reducing the time and effort of manual (radiologist) examinations. Furthermore, deep learning models can effectively aid in the diagnosis of diseases, including stroke (Xie et al, 2021), leukemia (Zhang et al, 2022), etc.…”
mentioning
confidence: 99%
“…DL models extract independent features unknown to clinicians; however, face challenges of explainability and interpretability which have been attempted to address by a neuro-symbolic learning study [20]. Deep learning has been applied in different domains specifically in diseases diagnosing, such as melanoma and diabetic retinopathy, and achieved comparable accuracy to that of human experts [44].…”
Section: Literature Studymentioning
confidence: 99%